Johnson & Johnson stated Wednesday it agreed to buy drugmaker Momenta Pharmaceuticals Inc. for about $6.5 billion, giving J&J entry into a possibly big-selling brand-new class of drugs to deal with specific autoimmune illness.81 for Momenta, a Cambridge, Mass., biotechnology company focused on establishing treatments of unusual immune-mediated illness.
source https://jobsearchtips.net/johnson-johnson-to-purchase-momenta-pharmaceuticals-for-6-5-billion/
No comments:
Post a Comment